131 related articles for article (PubMed ID: 17378442)
1. Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data.
Villa R; Cagnardi P; Belloli C; Zonca A; Zizzadoro C; Ferro E; Carli S
Equine Vet J; 2007 Mar; 39(2):136-42. PubMed ID: 17378442
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog.
Toutain PL; Cester CC; Haak T; Metge S
J Vet Pharmacol Ther; 2001 Feb; 24(1):35-42. PubMed ID: 11348485
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog.
Toutain PL; Cester CC; Haak T; Laroute V
J Vet Pharmacol Ther; 2001 Feb; 24(1):43-55. PubMed ID: 11348486
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic comparison of three pharmaceutical formulations of nimesulide in healthy volunteers.
Jovanović D; Kilibarda V; Todorović V; Potrebić O
Vojnosanit Pregl; 2005 Dec; 62(12):887-93. PubMed ID: 16375216
[TBL] [Abstract][Full Text] [Related]
6. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.
Rees WA; Harkins JD; Woods WE; Blouin RA; Lu M; Fenger C; Holland RE; Chambers TM; Tobin T
Equine Vet J; 1997 Mar; 29(2):104-10. PubMed ID: 9104558
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen.
Pohjolainen T; Jekunen A; Autio L; Vuorela H
Spine (Phila Pa 1976); 2000 Jun; 25(12):1579-85. PubMed ID: 10851109
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of nimesulide.
Bernareggi A
Clin Pharmacokinet; 1998 Oct; 35(4):247-74. PubMed ID: 9812177
[TBL] [Abstract][Full Text] [Related]
9. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
Lees P; Giraudel J; Landoni MF; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of etodolac in the horse following oral and intravenous administration.
Davis JL; Papich MG; Morton AJ; Gayle J; Blikslager AT; Campbell NB
J Vet Pharmacol Ther; 2007 Feb; 30(1):43-8. PubMed ID: 17217400
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug.
Suleyman H; Cadirci E; Albayrak A; Halici Z
Curr Med Chem; 2008; 15(3):278-83. PubMed ID: 18333314
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
Steiner AA; Li S; Llanos-Q J; Blatteis CM
Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and in vitro cyclooxygenase selectivity of deracoxib in horses.
Davis JL; Marshall JF; Papich MG; Blikslager AT; Campbell NB
J Vet Pharmacol Ther; 2011 Feb; 34(1):12-6. PubMed ID: 21219338
[TBL] [Abstract][Full Text] [Related]
14. Distribution of oral nimesulide in female genital tissues.
Pulkkinen MO; Vuento M; Macciocchi A; Monti T
Biopharm Drug Dispos; 1991 Mar; 12(2):113-7. PubMed ID: 2031992
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction.
Cornelisse CJ; Robinson NE; Berney CE; Kobe CA; Boruta DT; Derksen FJ
Equine Vet J; 2004 Jul; 36(5):426-30. PubMed ID: 15253084
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity and pharmacokinetic profile of a new parenteral formulation of nimesulide.
Gupta SK; Bhardwaj RK; Tyagi P; Sengupta S; Velpandian T
Pharmacol Res; 1999 Feb; 39(2):137-41. PubMed ID: 10072704
[TBL] [Abstract][Full Text] [Related]
17. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions.
Rainsford KD
Rheumatology (Oxford); 1999 May; 38 Suppl 1():4-10. PubMed ID: 10369399
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration.
Fernández-Varón E; Ayala I; Marín P; Carrión A; Martos N; Escudero E; Cárceles CM
Equine Vet J; 2006 Jul; 38(4):342-6. PubMed ID: 16866202
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
Giraudel JM; Toutain PL; King JN; Lees P
J Vet Pharmacol Ther; 2009 Feb; 32(1):31-40. PubMed ID: 19161453
[TBL] [Abstract][Full Text] [Related]
20. Quantification of nimesulide in human plasma by high-performance liquid chromatography with ultraviolet detector (HPLC-UV): application to pharmacokinetic studies in 28 healthy Korean subjects.
Kim MS; Park YS; Kim SH; Kim SY; Lee MH; Kim YH; Kim DW; Yang SC; Kang JS
J Chromatogr Sci; 2012 May; 50(5):396-400. PubMed ID: 22451531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
